MedTrace Logo

Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies

NCT05479305 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-05-01

No results posted yet for this study

Summary

The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft.

Clinical utility measures throughout the procedure and until discharge will be assessed

Conditions

  • Penetrating Ulcer of Aorta
  • Aneurysm Aortic
  • Type B Aortic Dissection
  • Residual Dissection After Type A Repair

Interventions

DEVICE

The Valiant Captivia Stent Graft

Aortic arch/Descending aorta Repair

Sponsors & Collaborators

  • European Cardiovascular Research Center

    collaborator NETWORK

  • Ceric Sàrl

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-21
Primary Completion
2024-11-30
Completion
2027-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05479305 on ClinicalTrials.gov